Valeur2022202320242025TTMFrais de vente, généraux et administratifs—4.28 B4.27 B4.22 B4.3 BRecherche et développement—1.21 B1.31 B1.26 B1.26 BRésultat d'exploitation—2.44 B2.63 B2.76 B2.65 BTotal des produits hors exploitation—511 M454 M449 M412 MCharges d'intérêts, nettes des intérêts capitalisés—616 M580 M540 M—Résultat hors exploitation, hors charges d'intérêts—-191 M-181 M-248 M318 MRevenus/dépenses exceptionnels—86 M55 M157 M94 MRésultat avant impôts—2.36 B2.58 B2.77 B2.58 BPart des actionnaires dans le résultat—11 M8 M3 M-3 MImpôts—743 M531 M614 M604 MIntérêts ne donnant pas le contrôle / intérêts minoritaires—46 M57 M70 M68 MAutres produits/charges après impôts—————Résultat net avant activités abandonnées—1.57 B1.99 B2.08 B1.91 BActivités abandonnées—-4 M00—Résultat net—1.57 B1.99 B2.08 B1.91 BAjustement de dilution—000—Dividendes privilégiés—183 M00—Résultat net dilué revenant aux actionnaires ordinaires—1.39 B1.99 B2.08 B1.91 BBénéfice par action de base (BPA de base)—3.054.374.564.18Bénéfice par action dilué (BPA dilué)—3.034.344.554.17Nombre moyen d'actions de base en circulation—455 M456 M456 M—Nombre d'actions en circulation après dilution—458 M459 M458 M—EBITDA—14.06 B14.09 B15.18 B16.23 BEBIT—13.45 B13.51 B14.6 B15.41 BCoût des ventes—————Autres coûts des ventes—————Amortissements (flux de trésorerie)—610 M580 M578 M814 M
GE HealthCare Technologies Inc. - Common Stock
GE Healthcare Technologies, Inc., stylized GE HealthCare, is an American health technology company based in Chicago, Illinois. It operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical Diagnostics, which manufactures contrast agents and radiopharmaceuticals.
GE HealthCare's primary customers are hospitals and health networks. In 2023, the company received 42% of its revenue in the United States and 13% of its revenue from China, where the company faces increasing competition.
GE HealthCare was originally the healthcare division of the American conglomerate General Electric, which spun it off in 2023 as an independent, publicly traded company. It operates in more than 100 countries, with GE HealthCare major regional operations in Buc, France; Helsinki, Finland; Kraków, Poland; Budapest, Hungary; Yizhuang, China; Hino & Tokyo, Japan, and Bangalore, India.